Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Completed · Not applicable
Conditions studied: Leukemia, Myelodysplastic Syndromes
In brief
RATIONALE: Gathering information about patients with myelodysplastic syndrome or acute myeloid leukemia who are discharged after finishing chemotherapy, or who stay in the hospital until blood counts return to normal, may help doctors learn more about a patient's quality of life, use of medical services, and the cost of these services. PURPOSE: This clinical trial is studying early discharge and outpatient care in patients who have undergone chemotherapy for myelodysplastic syndrome or acute myeloid leukemia.
Key facts
- Study ID
- NCT00844441
- Run by
- Fred Hutchinson Cancer Center
- People needed
- 96
- Starts
- 2008-12-01
- Expected to finish
- 2011-03-01
- Last updated by the study team
- 2011-05-19
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Oregon Health and Science University — Portland, Oregon, United States
- Fred Hutchinson Cancer Research Center — Seattle, Washington, United States
- Clinical Cancer Research Center at University Hospital Basel — Basel, Switzerland
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.